KACTUS Publishes Framework for 2+1 and Trispecific TCE Scaffold Design
WALTHAM, MA – KACTUS, a leading recombinant protein manufacturer, has published a technical framework for engineering 2+1 and trispecific T-cell engager (TCE) therapeutics. This new resource addresses critical structural scaffold challenges faced by drug discovery teams as they move beyond […]
KACTUS Publishes Framework for 2+1 and Trispecific TCE Scaffold Design Read More »


